Concepedia

Publication | Open Access

A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019

24

Citations

24

References

2022

Year

Abstract

NCT04602000; 2020-003369-20 (EudraCT).

References

YearCitations

Page 1